3 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 19097371 | PYRAZOLYL COMPOUNDS AS KV7 CHANNEL ACTIVATORS | KENYON, JOHN S | 1625 | Final Rejection | Apr 01, 2025 |
| 18261419 | USE OF RILUZOLE PRODRUGS TO TREAT ALZHEIMER'S DISEASE | WEIDNER, ADAM M | 1675 | Non-Final OA | Jul 13, 2023 |
| 17878121 | USE OF RILUZOLE, RILUZOLE PRODRUGS OR RILUZOLE ANALOGS WITH IMMUNOTHERAPIES TO TREAT CANCERS | JAVANMARD, SAHAR | 1622 | Final Rejection | Aug 01, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial